Merve Sibel GÜNGÖREN, Özlem YAYICI KÖKEN, Gülsüm İclal BAYHAN, Ayşegül Neşe ÇITAK KURT, Hamit ÖZYÜREK, Esra GÜRKAŞ, Pembe GÜLTUTAN, Deniz YILMAZ

Impact of COVID-19 on serum melatonin levels and sleep parameters in children

Background/aim: This study aimed to analyze the serum melatonin levels and changes in sleep patterns in pediatric patients with coronavirus disease 2019 (COVID-19). Materials and methods: This study was designed as a descriptive, cross-sectional study. Serum melatonin levels and sleep parameters of children with the diagnosis of COVID-19 who had mild and moderate disease (i.e., COVID-19 group) were compared with those of children admitted with non-COVID-19 nonspecific upper respiratory tract infection (i.e., control group). The sleep disturbance scale for children (SDSC) questionnaire was applied to the participants› primary caregivers to analyze their sleep patterns at present and six months before symptom onset and to investigate the impact of COVID-19 on sleep patterns. Results: The entire study cohort consisted of 106 patients. The COVID-19 group included 80 patients, while the control group consisted of 26 patients. The mean serum melatonin levels were 136.72 pg/mL and 172.63 pg/mL in the COVID-19 and control groups, respectively (p = 0.16). There was no significant difference between the groups in terms of 6 subcategories of the SDSC questionnaire regarding the present time and 6 months before symptom onset. The total SDSC scores were also similar in two different evaluation time points described above (p = 0.99). Conclusions: We conclude that COVID-19 did not impact the sleep parameters of children. Serum melatonin levels of all patients were higher than the reference range; however, they were higher in the non-COVID-19 patient group than the COVID-19 group. Since serum melatonin levels were higher than the reference values in children with COVID-19, and this disease is significantly less morbid in children, melatonin may have protective effects against COVID-19. Key words: Melatonin, sleep, pediatric, COVID-19, children

PDF

___

1. Zhang R, Wang X, Ni L, Di X, Ma B et al. COVID-19: melatonin as a potential adjuvant treatment. Life Sciences 2020; 250: 117583. doi: 10.1016/j.lfs.2020.117583
2. Waldhauser F, Weiszenbacher G, Tatzer E, Gisinger B, Waldhauser M et al. Alterations in nocturnal serum melatonin levels in humans with growth and aging. The Journal of Clinical Endocrinology and Metabolism 1988; 66 (3): 648-652. doi: 10.1210/jcem-66-3-648
3. García IG, Rodriguez-Rubio M, Mariblanca AR, De Soto LM, García LD et al. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARSCoV-2 infection in high-risk contacts (MeCOVID trial): a structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21 (1): 466. doi: 10.1186/s13063- 020-04436-6
4. Shneider A, Kudriavtsev A, Vakhrusheva A. Can melatonin reduce the severity of COVID-19 pandemic? International Reviews of Immunology 2020; 39 (4): 153-162. doi: 10.1080/08830185.2020.1756284
5. Bruni O, Ottaviano S, Guidetti V, Romoli M, Innocenzi M et al. The sleep disturbance scale for children (SDSC) construct ion and validation of an instrument to evaluate sleep disturbances in childhood and adolescence. Journal of Sleep Research 1996; 5 (4): 251-261. doi: 10.1111/j.1365-2869.1996.00251.x
6. Akçay D, Akçay B, Bozkurt Ö. Reliability and validity of Turkish sleep disturbance scale for children. Anatolian Journal of Psychiatry 2020; 21 (Suppl.1): 70-77. doi: 10.5455/apd.65084
7. Dong Y, Mo X, Hu Y, Qi X, Jiang F et al. Epidemiology of COVID-19 among children in China. Pediatrics 2020; 145 (6): e20200702. doi: 10.1542/peds.2020-0702
8. Anderson G, Reiter RJ. Melatonin: roles in influenza, Covid-19, and other viral infections. Reviews in Medical Virology 2020; 3 0(3): e2109. doi: 10.1002/rmv.2109
9. Elmahallawy EK, Luque JO, Aloweidi AS, Gutiérrez-Fernández J, Sampedro-Martínez A et al. Potential relevance of melatonin against some infectious agents: a review and assessment of recent research. Current Medicinal Chemistry 2015; 22 (33): 3848-3861. doi: 10.2174/0929867322666150827093730
10. Bonilla E, Valero N, Chacín-Bonilla L, Medina-Leendertz S. Melatonin and viral infections. Journal of Pineal Research 2004; 36 (2): 73-79. doi:10.1046/j.1600-079x.2003.00105.x
11. Vielma JR, Bonilla E, Chacín-Bonilla L, Mora M, MedinaLeendertz S et al. Effects of melatonin on oxidative stress, and resistance to bacterial, parasitic, and viral infections: a review. Acta Tropica 2014; 137: 31–38. doi: 10.1016/j. actatropica.2014.04.021
12. Molina Carballo A, Muñoz Hoyos A, Uberos Fernández J, Acuña Castroviejo D, Molina Font JA. Funcionalismo pineal (tasas de melatonina) en niños sanos de diferentes edades. Actualidad e interés del estudio de la glándula pineal en pediatría [Pineal functioning (melatonin levels) in healthy children of different ages. An update and the value of pineal gland study in pediatrics]. Anales Espanoles de Pediatria 1996; 45 (1): 33-44.
13. Crowley SJ, Cain SW, Burns AC, Acebo C, Carskadon MA. Increased sensitivity of the circadian system to light in early/ mid-puberty. The Journal of Clinical Endocrinology and Metabolism 2015; 100 (11): 4067-4073. doi: 10.1210/jc.2015- 2775
14. Eastin C, Eastin T. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. The Journal of Emergency Medicine 2020; 58 (4): 712-713. doi: 10.1542/peds.2020-0702
15. Tezer H, Bedir Demirdağ T. Novel coronavirus disease (COVID-19) in children. Turkish Journal of Medical Sciences 2020; 50 (SI-1): 592-603. doi: 10.3906/sag-2004-174
16. Gualano MR, Lo Moro G, Voglino G, Bert F, Siliquini R. Effects of COVID-19 lockdown on mental health and sleep disturbances in Italy. International Journal of Environmental Research and Public Health 2020; 17 (13): 4779. doi: 10.3390/ ijerph17134779
17. Li D-J, Ko N-Y, Chen Y-L, Wang P-W, Chang Y-P et al. COVID-19-related factors associated with sleep disturbance and suicidal thoughts among the Taiwanese public: a Facebook survey. International Journal of Environmental Research and Public Health 2020; 17 (12): 4779. doi: 10.3390/ijerph17124479
18. Beck F, Léger D, Fressard L, Peretti-Watel P, Verger P. COVID-19 health crisis and lockdown associated with high level of sleep complaints and hypnotic uptake at the population level. Journal of Sleep Research 2020; 30 (1); e13119. doi: 10.1111/jsr.13119
19. Zambrelli E, Canevini M, Gambini O, D’Agostino A. Delirium and sleep disturbances in COVID-19: a possible role for melatonin in hospitalized patients? Sleep Medicine 2020; 70: 111. doi: 10.1016/j.sleep.2020.04.006
20. Xie Z, Chen F, Li WA, Geng X, Li C et al. A review of sleep disorders and melatonin. Neurological Research 2017; 39 (6): 559-565. doi: 10.1080/ 01616412. 2017. 1315864
21. Middleton B. Measurement of melatonin and 6-sulphatoxymelatonin. Methods in Molecular Biology 2013; 1065: 171-199. doi: 10.1385/1-59259-986-9:235